Pacira BioSciences, Inc. company mark

Pacira BioSciences, Inc. Annual Report 2026

Official Filings · AI Report coming soon
Official Annual + Quarterly Filings
NASDAQ/NYSE: PCRX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Cap $1.06B
Source: SEC EDGAR
Business Intelligence Report
Not generated yet

Quality Scores

Business
Compounder
Management
Governance
Cash Flow
AI Quality Scores locked
Sign In to Generate One →

Latest Quarterly Earnings Summary

No quarterly summary yet

Generate the Business Intelligence Report to unlock AI earnings summary.

Sign In to Generate One →
Loading latest Annual Report…

Pacira BioSciences, Inc. Business Intelligence Hub

The Pacira BioSciences, Inc. Business Intelligence Hub is your central gateway to AI-powered company research, fundamental analysis, and equity research on Pacira BioSciences, Inc.. This page always opens the latest Business Intelligence annual report and stays in sync with Pacira BioSciences, Inc.'s newest 10-K filings, quarterly results and management commentary — so you're never reading stale analysis.

Pacira BioSciences, Inc. Financial Performance & Statements

Explore Pacira BioSciences, Inc.'s financial statements, revenue growth, net profit, EPS, book value, free cash flow and net worth trends over 5 and 10 years — with deterministic AI-validated numbers, not hallucinated summaries.

Pacira BioSciences, Inc. Quarterly Earnings & Management Commentary

Read the latest Pacira BioSciences, Inc. quarterly results, earnings summary, management commentary and concall highlights — cross-checked against the official filing.

Pacira BioSciences, Inc. Growth, Governance & Cash Flow Analysis

AI-graded scores on business compounding, compounder quality, management credibility, corporate governance and cash flow strength — the pillars of long-term business quality.

Pacira BioSciences, Inc. Sector, Valuation & Risk Analysis

See Pacira BioSciences, Inc. in context: sector analysis, industry analysis, competitive position, capital allocation, valuation context and key risks — surfaced from a decade of annual reports.

Related searches: Pacira BioSciences, Inc. annual report, Pacira BioSciences, Inc. AI annual report, Pacira BioSciences, Inc. fundamental analysis, Pacira BioSciences, Inc. business analysis, Pacira BioSciences, Inc. financial performance, Pacira BioSciences, Inc. financial statements, Pacira BioSciences, Inc. growth analysis, Pacira BioSciences, Inc. management analysis, Pacira BioSciences, Inc. corporate governance, Pacira BioSciences, Inc. cash flow analysis, Pacira BioSciences, Inc. business intelligence, Pacira BioSciences, Inc. valuation, Pacira BioSciences, Inc. quarterly results, Pacira BioSciences, Inc. earnings summary, Pacira BioSciences, Inc. management commentary, Pacira BioSciences, Inc. sector analysis, Pacira BioSciences, Inc. company research, Pacira BioSciences, Inc. equity research, Pacira BioSciences, Inc. stock analysis, Pacira BioSciences, Inc. AI company analysis, Pacira BioSciences, Inc. capital allocation, Pacira BioSciences, Inc. risk analysis, Pacira BioSciences, Inc. competitive position, Pacira BioSciences, Inc. long-term growth.